Colônia de férias PIBID educação física FURG 2013: uma experiência no contexto da docência

Trabalho apresentado no 31º SEURS - Seminário de Extensão Universitária da Região Sul, realizado em Florianópolis, SC, no período de 04 a 07 de agosto de 2013 - Universidade Federal de Santa Catarina.Este artigo vem abordar e refletir a respeito de alguns pontos sobre a I Colônia de Férias – PIBID/EF, desenvolvida pelo grupo de bolsistas vinculados ao Programa Institucional de Bolsa de Iniciação a Docência – PIBID. O objetivo desta colônia foi dar um enfoque na formação dos acadêmicos do grupo trazendo o foco para uma metodologia voltada para um público específico, em um contexto específico. A Colônia de Férias foi realizada no campus da Universidade Federal do Rio Grande - FURG, sucedeu-se em 5 dias: 2 de formação, 2 de realização e 1 de avaliação. Participaram 35 crianças entre 8 á 14 anos. Esse evento nos proporcionou experiência em organização, planejamento e instrução de uma colônia de férias, bem como o entendimento de trabalho coletivo e a reflexão da prática docente

Monotributo

El Monotributo es una forma sencilla y práctica que tienen los trabajadores, profesionales y comerciantes de bajos ingresos de sumarse a la economía formal y tener obra social, emitir facturas y aportar a la futura jubilación. A diferencia de los autónomos regulares, que están inscriptos en el IVA y/o Impuestos a las Ganancias y/o Régimen de Autónomos, los monotributistas también son trabajadores independientes pero sus ingresos no pueden superar un máximo anual determinado, y hacen un solo pago al mes que contempla tanto el impuesto al Estado, la obra social y el aporte jubilatorio todo en uno. Pueden inscribirse como monotributistas quienes tienen un oficio del que viven; quienes son profesionales y que ganan hasta una suma determinada; quienes tienen una renta que proviene de alquileres de inmuebles propios (no más de 3 propiedades); quienes tienen un comercio pequeño y también cualquier emprendedor de un proyecto de bajos ingresos incluso formando una cooperativa de no más de 3 socios. El Régimen Simplifi ado para Pequeños Contribuyentes se implementó en Argentina en noviembre de 1998 y permitió que mucha gente que no podía pagar la cuota de autónomo general, se sumara a la economía formal obteniendo beneficios con los que no contaba hasta entonces, como la obra social y la jubilación. Existen distintas categorías dentro del Monotributo que están armadas de acuerdo a los ingresos anuales y que marcan el aporte mensual que el monotributista deberá hacer al Estado. Hay en la actualidad 11 categorías de Monotributo que van de la categoría A hasta la categoría K. La categoría a la que pertenece un monotributista se ajusta cada 6 meses: los días 20 de enero y 20 de julio. Y bajará su pago mensual si está facturando menos o subirá si está facturando más.Fil: Ascurra, Yanina Pamela. Universidad Nacional de Cuyo. Facultad de Ciencias Económicas.Fil: Canuso, Rebeca Mabel. Universidad Nacional de Cuyo. Facultad de Ciencias Económicas

Role of paliperidone extended-release in treatment of schizoaffective disorder

Schizoaffective disorder is characterized by the presence of symptoms of both schizophrenia and a major mood disorder. The coexistence of these symptoms can be difficult to manage, and these patients are generally treated with antipsychotics as well as mood stabilizers and/or antidepressants. Additionally, no established treatment guidelines exist for this disorder. This review describes the combined results of two international, double-blind, placebo-controlled clinical studies of paliperidone extended-release (ER), an atypical antipsychotic recently approved in the US for the treatment of schizoaffective disorder. Subjects in these six-week trials were aged 18–65 years, had a diagnosis of schizoaffective disorder based on the Structural Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) Disorders, and were experiencing an acute exacerbation. The subjects from these studies had significant symptomatology as evidenced by a mean (standard deviation) baseline Positive and Negative Syndrome Scale total score of 92.8 (13.0). Based on Young Mania Rating Scale and/or a 21-item Hamilton Rating Scale for Depression score of ≥16 at baseline, 79.5% and 66.9% of subjects presented with prominent manic and depressive symptoms, respectively, and 46.4% presented with mixed symptoms. Approximately half (45%) of subjects were taking adjunctive mood stabilizers and/or antidepressants. Paliperidone ER was found to be effective in improving psychotic and mood symptoms in these subjects. Paliperidone ER was also effective as monotherapy or adjunctive to mood stabilizers and/or antidepressants for subjects with prominent manic, depressive, or mixed symptoms at baseline. No new tolerability signals were observed in this population. To the best of our awareness, these pooled data provide the largest data set of patients with schizoaffective disorder, and extend our knowledge of disease characteristics and treatment response

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

<p>Abstract</p> <p>Background</p> <p>To compare the efficacy and tolerability of paliperidone extended-release (ER) with risperidone immediate-release using propensity score methodology.</p> <p>Methods</p> <p>Six double-blind, randomized, placebo-controlled, short-term clinical trials for acute schizophrenia with availability of individual patient-level data were identified (3 per compound). Propensity score pairwise matching was used to balance observed covariates between the paliperidone ER and risperidone patient populations. Scores were generated using logistic regression models, with age, body mass index, race, sex, baseline Positive and Negative Syndrome Scale (PANSS) total score and baseline Clinical Global Impressions–Severity (CGI-S) score as factors. The dosage range of paliperidone ER (6-12 mg/day) was compared with 2 risperidone dosage ranges: 2-4 and 4-6 mg/day. The primary efficacy measure was change in PANSS total score at week 6 end point. Tolerability end points included adverse event (AE) reports and weight. AEs with rates ≥5% and with a ≥2% difference between paliperidone ER and risperidone were identified.</p> <p>Results</p> <p>Completion rates for placebo-treated subjects in paliperidone ER trials (n = 95) and risperidone trials (n = 122) groups were 36.8% and 51.6%, respectively; end point changes on PANSS total scores were similar (p = 0.768). Completion rates for subjects receiving paliperidone ER 6-12 mg/day (n = 179), risperidone 2-4 mg/day (n = 113) or risperidone 4-6 mg/day (n = 129) were 64.8%, 54.0% and 66.7%, respectively (placebo-adjusted rates: paliperidone ER vs risperidone 2-4 mg/day, p = 0.005; paliperidone ER vs risperidone 4-6 mg/day, p = 0.159). PANSS total score improvement with paliperidone ER was greater than with risperidone 2-4 mg/day (difference in mean change score, -6.7; p < 0.05) and similar to risperidone 4-6 mg/day (0.2; p = 0.927). Placebo-adjusted AEs more common with paliperidone ER were insomnia, sinus tachycardia and tachycardia; more common with risperidone were somnolence, restlessness, nausea, anxiety, salivary hypersecretion, akathisia, dizziness and nasal congestion. Weight changes with paliperidone ER and risperidone were similar (paliperidone ER vs risperidone 2-4 mg/day, p = 0.489; paliperidone ER vs risperidone 4-6 mg/day, p = 0.236).</p> <p>Conclusions</p> <p>This indirect database analysis suggested that paliperidone ER 6-12 mg/day may be more efficacious than risperidone 2-4 mg/day and as efficacious as risperidone 4-6 mg/day. The AE-adjusted incidence rates suggest differences between treatments that may be relevant for individual patients. Additional randomized, direct, head-to-head clinical trials are needed to confirm these findings.</p

Parenting Enhancement, Interpersonal Psychotherapy to Reduce Depression in Low-Income Mothers of Infants and Toddlers: A Randomized Trial

Depressive symptoms and clinical depression are highly prevalent in low-income mothers and negatively affect their infants and toddlers

Short-term in-home intervention reduces depressive symptoms in early head start Latina mothers of infants and toddlers

Depressive symptoms may compromise the ability of low-income Latina mothers with limited English language proficiency to parent their infants or toddlers. Eighty Early Head Start Latina mothers with limited English language proficiency were randomized to an advanced practice nurse-delivered, culturally tailored, in-home psychotherapy intervention, or to usual care. Repeated measures regression analysis showed a significantly greater decrease in depressive symptoms for intervention mothers compared to the usual care group at 22 and 26 weeks (4 weeks post intervention). Intervention mothers’ reports of their child's aggression diminished significantly from T1 to T4 compared to usual care mothers (p= .03). Self-efficacy appeared to only partially mediate the intervention effect, and maternal health moderated the intervention impact. Results indicate that the intervention reduced depressive symptoms and, compared to previous studies in this population, retention of mothers in both intervention and control conditions was improved